# CSL Plasma Inc. – FDA Inspection, Jan 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/b9682f55-38e3-499c-86de-485c83c253f9
Source feed: FDA_Inspections

> FDA inspection 1195620 of CSL Plasma Inc., January 17, 2023. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195620
- Company Name: CSL Plasma Inc.
- Inspection Date: 2023-01-17
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1037426 - 2017-11-08
- FDA Inspection 825769 - 2013-03-28
- FDA Inspection 715928 - 2011-03-23
- FDA Inspection 545399 - 2008-11-03

## Related Officers

- [Erma Zaimova](https://www.keypedia.com/people/erma-zaimova/87da23ad-48bb-4096-9d8a-e8511c6b5c98)

Company: https://www.keypedia.com/companies/csl-plasma-inc/6cea5e3d-d65e-4b3a-a37c-b88b1d7485cd

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d